ZIMMER BIOMET HOLDINGS, INC. Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Net of Tax (Deprecated 2012-01-31)
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Net of Tax (Deprecated 2012-01-31) of -$900.00 thousand for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-03.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax · last filed 2012-05-03
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), reclassification adjustment on derivatives included in net income, net of tax (deprecated 2012-01-31) for the quarter ending 2012-03-31 was -$900.00K.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), reclassification adjustment on derivatives included in net income, net of tax (deprecated 2012-01-31) for the quarter ending 2011-12-31 was -$2.80M.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), reclassification adjustment on derivatives included in net income, net of tax (deprecated 2012-01-31) for the quarter ending 2011-09-30 was -$8.50M, a 257.41% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), reclassification adjustment on derivatives included in net income, net of tax (deprecated 2012-01-31) for the quarter ending 2011-06-30 was -$8.80M, a 206.02% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), reclassification adjustment on derivatives included in net income, net of tax (deprecated 2012-01-31) for fiscal 2011 was -$24.50M, a 311.21% decline from fiscal 2010.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), reclassification adjustment on derivatives included in net income, net of tax (deprecated 2012-01-31) for fiscal 2010 was $11.60M, a 35.91% decline from fiscal 2009.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), reclassification adjustment on derivatives included in net income, net of tax (deprecated 2012-01-31) for fiscal 2009 was $18.10M, a 58.29% decline from fiscal 2008.
- ZIMMER BIOMET HOLDINGS, INC. other comprehensive income (loss), reclassification adjustment on derivatives included in net income, net of tax (deprecated 2012-01-31) for fiscal 2008 was $43.40M, a 60.74% increase from fiscal 2007.
| Period end | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Net of Tax (Deprecated 2012-01-31) 3 month | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Net of Tax (Deprecated 2012-01-31) 3 month as first filed | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Net of Tax (Deprecated 2012-01-31) 6 month | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Net of Tax (Deprecated 2012-01-31) 6 month as first filed | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Net of Tax (Deprecated 2012-01-31) 9 month | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Net of Tax (Deprecated 2012-01-31) 9 month as first filed | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Net of Tax (Deprecated 2012-01-31) 12 month | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Net of Tax (Deprecated 2012-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2012-03-31 | -$900.00K 10-Q · filed 2012-05-03 | -$3.70M derived: sum of 2 quarters · filed 2012-05-03 | -$12.20M derived: sum of 3 quarters · filed 2012-05-03 | -$21.00M derived: sum of 4 quarters · filed 2012-05-03 | ||||
| 2011-12-31 | -$2.80M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | -$11.30M derived: sum of 2 quarters · filed 2012-02-27 | -$20.10M derived: sum of 3 quarters · filed 2012-02-27 | -$24.50M 10-K · filed 2012-02-27 | ||||
| 2011-09-30 | -$8.50M 10-Q · filed 2011-11-02 | -$17.30M derived: sum of 2 quarters · filed 2011-11-02 | -$21.70M 10-Q · filed 2011-11-02 | -$24.70M derived: sum of 4 quarters · filed 2012-05-03 | ||||
| 2011-06-30 | -$8.80M 10-Q · filed 2011-08-08 | -$13.20M 10-Q · filed 2011-08-08 | -$16.20M derived: sum of 3 quarters · filed 2012-05-03 | -$10.80M derived: sum of 4 quarters · filed 2012-05-03 | ||||
| 2011-03-31 | -$4.40M 10-Q · filed 2012-05-03 | $4.40M 10-Q · filed 2011-05-05 | -$7.40M derived: sum of 2 quarters · filed 2012-05-03 | -$2.00M derived: sum of 3 quarters · filed 2012-05-03 | $6.30M derived: sum of 4 quarters · filed 2012-05-03 | |||
| 2010-12-31 | -$3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $2.40M derived: sum of 2 quarters · filed 2012-02-27 | $10.70M derived: sum of 3 quarters · filed 2012-02-27 | $11.60M 10-K · filed 2012-02-27 | -$11.60M 10-K · filed 2011-02-25 | |||
| 2010-09-30 | $5.40M 10-Q · filed 2011-11-02 | -$5.40M 10-Q · filed 2010-11-03 | $13.70M derived: sum of 2 quarters · filed 2011-11-02 | $14.60M 10-Q · filed 2011-11-02 | -$14.60M 10-Q · filed 2010-11-03 | $47.80M derived: sum of 4 quarters · filed 2012-02-27 | ||
| 2010-06-30 | $8.30M 10-Q · filed 2011-08-08 | -$8.30M 10-Q · filed 2010-08-05 | $9.20M 10-Q · filed 2011-08-08 | -$9.20M 10-Q · filed 2010-08-05 | $42.40M derived: sum of 3 quarters · filed 2012-02-27 | $37.80M derived: sum of 4 quarters · filed 2012-02-27 | ||
| 2010-03-31 | -$900.00K 10-Q · filed 2011-05-05 | $34.10M derived: sum of 2 quarters · filed 2012-02-27 | $29.50M derived: sum of 3 quarters · filed 2012-02-27 | $23.30M derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2009-12-31 | $35.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $30.40M derived: sum of 2 quarters · filed 2012-02-27 | $24.20M derived: sum of 3 quarters · filed 2012-02-27 | $18.10M 10-K · filed 2012-02-27 | -$18.10M 10-K · filed 2010-02-25 | |||
| 2009-09-30 | -$4.60M 10-Q · filed 2010-11-03 | -$10.80M derived: sum of 2 quarters · filed 2010-11-03 | -$16.90M 10-Q · filed 2010-11-03 | |||||
| 2009-06-30 | -$6.20M 10-Q · filed 2010-08-05 | -$12.30M 10-Q · filed 2010-08-05 | ||||||
| 2008-12-31 | $43.40M 10-K · filed 2011-02-25 | |||||||
| 2007-12-31 | $27.00M 10-K · filed 2010-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |